|
I don't like pubs http://www.youni.ir/combivent-respimat-metered-doses-bc2b.pdf#stayed precio del combivent Third Point Re kept its initial draft IPO prospectus confidential in May while the U.S. Securities and Exchange Commission reviewed it. Such confidentiality is permitted for emerging growth companies under the JOBS Act, and contrasts with the usual approach of larger U.S. IPOs. A revised Third Point Re filing and the first draft were made public in July.
|